Cellectis to Hold Fourth Quarter and Full Year 2019 ... Cellectis to Hold Fourth Quarter and Full Year 2019 Earnings Call on Thursday, March 5, 2020 at 7:30 AM EST CLLS: Cellectis S.A. (CLLS): Earnings News - Stock News Nov 13, 2017 · CLLS had returned +47.85% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period. More Info About Cellectis S.A. (CLLS) Cellectis SA is a preclinical stage biopharmaceutical company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART).
Mar 31, 2020 Cellectis S.A. (CLLS) latest earnings report: revenue, EPS, surprise, history, news and analysis.
Cellectis S.A eps - earnings per share from 2015 to 2019. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants. Cellectis Stock Price History + Charts (CLLS) • Dogs of ... The following presents a detailed Cellectis stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Cellectis stock chart which you can easily adjust to the time frame of your choosing (e.g. using the scroll bar or pinch and zoom on a touch screen). CLLS Cellectis S.A. Stock Quote - FINVIZ.com Should Cellectis SA.s (NASDAQ:CLLS) Recent Earnings Decline Worry You? Simply Wall St. Jun-05-18 07:35AM : Detailed Research: Economic Perspectives on Galapagos NV, Cellectis S.A, MediciNova, Logitech International S.A, The Descartes Systems Group, and Canadian Pacific Railway What Drives Growth in Today's Competitive Landscape GlobeNewswire CLLS Stock Price & Charts | Cellectis
ALCLS:EN Paris Stock Quote - Cellectis SA - Bloomberg Markets
CLLS Cellectis S.A. Earnings Date History and Options Price Movements Analysis Exclusive Update To quantify how volatile a stock behaves after its earnings announcement we assign each stock an EARNINGS VOLATILITY RATING (EVR). NASDAQ:CLLS Cellectis S.A. - Stock Market Mentor Cellectis S.A. (NASDAQ:CLLS) There are currently no videos for this stock. To request coverage of this stock, please click the green request video box on the right. Cellectis SA - NASDAQ:CLLS - Stock Quote & News - TheStreet Mar 13, 2020 · View detailed financial information, real-time news, videos, quotes and analysis on Cellectis SA (NASDAQ:CLLS). Explore commentary on Cellectis SA … Cellectis to Hold Fourth Quarter and Full Year 2019 ... Cellectis to Hold Fourth Quarter and Full Year 2019 Earnings Call on Thursday, March 5, 2020 at 7:30 AM EST
Cellectis S.A. (CLLS) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term
Apr 01, 2020 · Following Series of US and European Patent Grants, Cellectis Strengthens its Intellectual Property on CRISPR-Edited T-cell Therapies Regulatory News: Cellectis (CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells, today announced that a new patent from the US Patent and Trademark Office had been … CLLS Stock Price Quote & News - Cellectis | Robinhood You can watch CLLS and buy and sell other stock and options commission-free on Robinhood. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Cellectis against related stocks people have also bought. Earnings for Cellectis S.A.
Cellectis S.A. American Depositary Shares (CLLS) Stock ...
Mar 05, 2020 · Cellectis S.A. American Depositary Shares (CLLS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Cellectis - CLLS - Stock Price & News | The Motley Fool Real time Cellectis (CLLS) stock price quote, stock The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. CLLS earnings call for the period Cellectis S.a. - CLLS - Stock Price Today - Zacks View Cellectis S.A. CLLS investment & stock information. Get the latest Cellectis S.A. CLLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
CLLS stock rating and analysis - Cellectis : a summary of key financial strength and profitability metrics. 3-Year Revenue Growth Rate, -35.6. N/A.